Pharmaceutical

A rational design approach to RNA targeting could replace large-scale screening

At ELRIG 2024, Dr. Maria Duca described how her lab’s rational design approach bypasses lengthy screening protocols.

Oct 6, 2024 - 04:00
A rational design approach to RNA targeting could replace large-scale screening
At ELRIG 2024, Dr. Maria Duca described how her lab’s rational design approach bypasses lengthy screening protocols.
Read the original article

Tags:

Previous Article

Resilience secures funds to enhance production of essential medicine components

Next Article

Neuvivo makes bid to enter ALS arena with immunotherapy candidate

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Signal: PureHealth UK expansion shows continued focus on healthcare in UAE

Signal: PureHealth UK expansion shows continued focus o...

Aug 30, 2023

Private equity deals in pharmaceutical in Germany incre...

Jul 31, 2023

National Resilience secures funding for domestic biomanufacturing capacity

National Resilience secures funding for domestic bioman...

Mar 27, 2023